Elsa Shapiro

8.0k total citations
147 papers, 5.2k citations indexed

About

Elsa Shapiro is a scholar working on Physiology, Molecular Biology and Rheumatology. According to data from OpenAlex, Elsa Shapiro has authored 147 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Physiology, 30 papers in Molecular Biology and 30 papers in Rheumatology. Recurrent topics in Elsa Shapiro's work include Lysosomal Storage Disorders Research (84 papers), Glycogen Storage Diseases and Myoclonus (28 papers) and Metabolism and Genetic Disorders (17 papers). Elsa Shapiro is often cited by papers focused on Lysosomal Storage Disorders Research (84 papers), Glycogen Storage Diseases and Myoclonus (28 papers) and Metabolism and Genetic Disorders (17 papers). Elsa Shapiro collaborates with scholars based in United States, United Kingdom and Germany. Elsa Shapiro's co-authors include William Krivit, Lawrence A. Lockman, Charles Peters, Kathleen Delaney, Daniel J. Loes, Chester B. Whitley, Paul J. Orchard, Julie B. Eisengart, Lawrence Charnas and Kendra Bjoraker and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Blood.

In The Last Decade

Elsa Shapiro

143 papers receiving 5.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elsa Shapiro United States 38 2.9k 1.5k 1.1k 677 639 147 5.2k
Chester B. Whitley United States 39 3.5k 1.2× 1.6k 1.1× 1.4k 1.3× 555 0.8× 908 1.4× 201 5.1k
Marc C. Patterson United States 46 3.4k 1.2× 2.3k 1.5× 737 0.7× 387 0.6× 611 1.0× 172 6.5k
Maria L. Escolar United States 33 2.0k 0.7× 917 0.6× 805 0.8× 245 0.4× 330 0.5× 121 3.4k
Christian J. Hendriksz United Kingdom 34 2.8k 0.9× 644 0.4× 1.0k 1.0× 426 0.6× 1.0k 1.6× 135 3.7k
Robert D. Steiner United States 45 1.5k 0.5× 2.6k 1.7× 946 0.9× 1.1k 1.7× 994 1.6× 201 6.8k
J. E. Wraith United Kingdom 37 4.2k 1.4× 573 0.4× 1.9k 1.7× 204 0.3× 1.3k 2.1× 84 5.0k
Christine M. Eng United States 34 2.7k 0.9× 1.3k 0.9× 1.3k 1.2× 168 0.2× 984 1.5× 81 5.7k
Gregory M. Pastores United States 50 7.5k 2.6× 2.2k 1.4× 3.1k 2.9× 281 0.4× 1.4k 2.2× 204 8.8k
Robert J. Hopkin United States 40 2.8k 1.0× 1.5k 1.0× 1.5k 1.4× 153 0.2× 1.2k 1.9× 189 5.8k
Brian Lake United Kingdom 38 1.8k 0.6× 1.9k 1.3× 377 0.4× 601 0.9× 385 0.6× 140 4.4k

Countries citing papers authored by Elsa Shapiro

Since Specialization
Citations

This map shows the geographic impact of Elsa Shapiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elsa Shapiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elsa Shapiro more than expected).

Fields of papers citing papers by Elsa Shapiro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elsa Shapiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elsa Shapiro. The network helps show where Elsa Shapiro may publish in the future.

Co-authorship network of co-authors of Elsa Shapiro

This figure shows the co-authorship network connecting the top 25 collaborators of Elsa Shapiro. A scholar is included among the top collaborators of Elsa Shapiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elsa Shapiro. Elsa Shapiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wijburg, Frits A., Stewart Rust, Jessica de Ruijter, et al.. (2021). Long-term safety and clinical outcomes of intrathecal heparan-N-sulfatase in patients with Sanfilippo syndrome type A. Molecular Genetics and Metabolism. 134(4). 317–322. 6 indexed citations
2.
Rizopoulos, Dimitris, Maarten H. Lequin, Femke K. Aarsen, et al.. (2020). Can serial cerebral MRIs predict the neuronopathic phenotype of MPS II?. Journal of Inherited Metabolic Disease. 44(3). 751–762. 3 indexed citations
3.
Shapiro, Elsa, et al.. (2019). Analysis of the caregiver burden associated with Sanfilippo syndrome type B: panel recommendations based on qualitative and quantitative data. Orphanet Journal of Rare Diseases. 14(1). 168–168. 23 indexed citations
4.
Shapiro, Elsa, Chester B. Whitley, & Julie B. Eisengart. (2018). Beneath the floor: re-analysis of neurodevelopmental outcomes in untreated Hurler syndrome. Orphanet Journal of Rare Diseases. 13(1). 76–76. 18 indexed citations
5.
Whitley, Chester B., Maureen Cleary, Eugen Mengel, et al.. (2018). Observational Prospective Natural History of Patients with Sanfilippo Syndrome Type B. The Journal of Pediatrics. 197. 198–206.e2. 25 indexed citations
6.
Eisengart, Julie B., Kyle Rudser, Yong Xue, et al.. (2018). Long-term outcomes of systemic therapies for Hurler syndrome: an international multicenter comparison. Genetics in Medicine. 20(11). 1423–1429. 43 indexed citations
7.
Wijburg, Frits A., Chester B. Whitley, Joseph Muenzer, et al.. (2018). Intrathecal heparan-N-sulfatase in patients with Sanfilippo syndrome type A: A phase IIb randomized trial. Molecular Genetics and Metabolism. 126(2). 121–130. 37 indexed citations
8.
Lee, Johanna H. van der, J. Morton, Heather Adams, et al.. (2017). Cognitive endpoints for therapy development for neuronopathic mucopolysaccharidoses: Results of a consensus procedure. Molecular Genetics and Metabolism. 121(2). 70–79. 32 indexed citations
9.
Delaney, Kathleen, et al.. (2017). Cognitive and adaptive measurement endpoints for clinical trials in mucopolysaccharidoses types I, II, and III: A review of the literature. Molecular Genetics and Metabolism. 121(2). 57–69. 19 indexed citations
10.
Semrud‐Clikeman, Margaret, et al.. (2016). Selecting measures for the neurodevelopmental assessment of children in low- and middle-income countries. Child Neuropsychology. 23(7). 761–802. 63 indexed citations
11.
Shapiro, Elsa, Heather Adams, Ann Barbier, et al.. (2016). Neurocognitive clinical outcome assessments for inborn errors of metabolism and other rare conditions. Molecular Genetics and Metabolism. 118(2). 65–69. 26 indexed citations
12.
Rudser, Kyle, et al.. (2014). Acquired Autistic Behaviors in Children with Mucopolysaccharidosis Type IIIA. The Journal of Pediatrics. 164(5). 1147–1151.e1. 39 indexed citations
13.
Ahmed, Alia, Chester B. Whitley, Kyle Rudser, et al.. (2013). Neurocognitive and neuropsychiatric phenotypes associated with the mutation L238Q of the α-L-iduronidase gene in Hurler–Scheie syndrome. Molecular Genetics and Metabolism. 111(2). 123–127. 24 indexed citations
14.
Tolar, Jakub, Kendra Bjoraker, C B Whitley, et al.. (2007). Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome. Bone Marrow Transplantation. 41(6). 531–535. 99 indexed citations
15.
Potegal, Michael, et al.. (2007). Sequence and priming in 15 month‐olds' reactions to brief arm restraint: evidence for a hierarchy of anger responses. Aggressive Behavior. 33(6). 508–518. 9 indexed citations
16.
Shapiro, Elsa, Elizabeth Braunlin, Lawrence Charnas, et al.. (2003). Continued neurocognitive development and prevention of cardiopulmonary complications after successful BMT for I-cell disease: a long-term follow-up report. Bone Marrow Transplantation. 32(9). 957–960. 29 indexed citations
17.
Jordan, Catherine, Patricia Lee, & Elsa Shapiro. (2000). Measuring developmental outcomes of lead exposure in an urban neighborhood: the challenges of community-based research. Journal of Exposure Science & Environmental Epidemiology. 10(S6). 732–742. 12 indexed citations
18.
19.
Krivit, William, Martin R. Klemperer, M J Cowan, et al.. (1995). Survival in Hurler's disease following bone marrow transplantation in 84 patients. Bone Marrow Transplantation. 15(1). 14 indexed citations
20.
Shapiro, Elsa, Lawrence A. Lockman, David S. Knopman, & William Krivit. (1994). Characteristics of the dementia in late‐onset metachromatic leukodystrophy. Neurology. 44(4). 662–662. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chester B. Whitley Breakdown of academic impact, for papers by Marc C. Patterson Breakdown of academic impact, for papers by Maria L. Escolar Breakdown of academic impact, for papers by Christian J. Hendriksz Breakdown of academic impact, for papers by Robert D. Steiner Breakdown of academic impact, for papers by J. E. Wraith Breakdown of academic impact, for papers by Christine M. Eng Breakdown of academic impact, for papers by Gregory M. Pastores Breakdown of academic impact, for papers by Robert J. Hopkin Breakdown of academic impact, for papers by Brian Lake
Rankless by CCL
2026